Circulation

NOVEMBER 11, 2024

Introduction:Smoking is a well-known risk factor for atherosclerotic cardiovascular disease and kidney failure among patients with chronic kidney disease (CKD). Circulation, Volume 150, Issue Suppl_1 , Page A4142036-A4142036, November 12, 2024. However, the association of former and current smoking status (vs.

Kidney Disease 40

Kidney Disease Heart Failure Blood Pressure Public Health 40

Med Page Today

MARCH 15, 2024

(MedPage Today) -- A computerized clinical decision support (CDS) tool for primary care helped lower blood pressure (BP) in patients with chronic kidney disease (CKD) and uncontrolled hypertension, a cluster-randomized trial found. When primary.

Hypertension 115

Hypertension Kidney Disease Blood Pressure 115

Journal of the American Heart Association

DECEMBER 18, 2023

BackgroundBoth nighttime systolic blood pressure and pulse rate are associated with adverse outcomes in patients with chronic kidney disease (CKD). However, nighttime double product (DP), which is the product of nighttime systolic blood pressure and pulse rate, has not yet been investigated in this context.

Kidney Disease 40

Kidney Disease Hypertension Blood Pressure Risk Factors 40

Journal of the American Heart Association

DECEMBER 8, 2023

BackgroundChronic kidney disease (CKD) is closely associated with cardiovascular disease. Meanwhile, higher scores for blood glucose (odds ratio, for each 10‐point increase, 0.88 [95% CI, 0.87–0.90]) 0.90]) and blood pressure (odds ratio, for each 10‐point increase, 0.92 [95% CI, 0.91–0.94])

Kidney Disease 45

Kidney Disease Blood Pressure Cardiovascular Disease 45

Journal of Clinical Investigation - Cardiology

JANUARY 2, 2024

Mineralocorticoid excess commonly leads to hypertension (HTN) and kidney disease. However, finerenone was particularly effective in reducing albuminuria and improving gene expression changes in podocytes and proximal tubule cells, even with an equivalent reduction in blood pressure.

Kidney Disease 132

Kidney Disease Blood Pressure Hypertension 132

American College of Cardiology

OCTOBER 3, 2024

Patients with chronic kidney disease (CKD) whose systolic blood pressure (SBP), LDL-C and fasting blood glucose (FBG) were controlled to target levels experienced a similar number of primary outcome events as patients without CKD, according to a new study published in JACC.

Kidney Disease 40

Kidney Disease Blood Pressure Outcomes Article 40

Hypertension Journal

SEPTEMBER 14, 2023

BACKGROUND:Hypertension frequently accompanies chronic kidney disease (CKD) as etiology and sequela. Hypertension, Volume 80, Issue 12 , Page 2533-2543, December 1, 2023. We defined CKD as a sustained estimated glomerular filtration rate value <60 mL/min per 1.73 m2or a urine albumin-to-creatinine ratio ≥30 mg/g.

Kidney Disease 40

Kidney Disease Hypertension Blood Pressure Outcomes 40

American College of Cardiology

MARCH 22, 2024

Does a computerized clinical decision support (CDS) system based on behavioral economic principles and human-centered design lead to a decrease in systolic blood pressure (SBP) in patients with chronic kidney disease (CKD) and uncontrolled hypertension?

Hypertension 52

Hypertension Kidney Disease Blood Pressure Article 52

Cardiometabolic Health Congress

NOVEMBER 16, 2023

Key findings presented at the conference included disparities in access to kidney transplantation and waitlisting based on race and neighborhood characteristics, racial and ethnic differences in incident chronic kidney disease (CKD), and the use of motivational strategies to improve dialysis nonadherence among African American patients.

Kidney Disease 52

Kidney Disease Blood Pressure Diabetes Hospital 52

Frontiers in Cardiovascular Medicine

MARCH 3, 2024

Background Preeclampsia (PE) is associated with subsequent higher risk of cardiovascular and kidney disease. Serum copeptin, as a proxy for vasopressin, and urinary uromodulin, were associated with PE physiopathology and kidney functional mass respectively.

Blood Pressure 64

Blood Pressure Kidney Disease Hypertension Hospital 64

DAIC

JANUARY 19, 2024

AVIM therapy is an investigational patented bioelectronic therapy, administered using a standard dual-chamber pacemaker, designed to immediately, substantially and persistently reduce blood pressure. mmHg in office systolic blood pressure (oSBP) at six months when compared to control patients. Suman Pasupuleti, M.D.

Pacemaker 105

Pacemaker Hypertension Blood Pressure Kidney Disease 105

Circulation

NOVEMBER 11, 2024

Introduction:Blood pressure targets for the elderly are still controversial, there is a lack of certainty about the benefit and safety of targeting ≤ 130mmHg systolic blood pressure. of patients had cardiovascular disease, 10.9% chronic kidney disease. diabetes, and 15.5%

Blood Pressure 40

Blood Pressure Hypertension Kidney Disease Outcomes 40

Open Heart

MARCH 23, 2023

It is risk factor for cardiovascular disease, stroke and kidney disease. Hence, this study aimed to assess blood pressure (BP) self-monitoring practice and associated factors among adult hypertensive patients on follow-up in South Wollo Zone public hospitals, Northeast Ethiopia.

Blood Pressure 40

Blood Pressure Hypertension Hospital Kidney Disease 40

CardiacWire

OCTOBER 6, 2024

Finerenone is a non-steroidal, selective mineralocorticoid receptor antagonist (nsMRA), blocking the mineralocorticoid receptor and its blood pressure effects. Finerenone is already approved to reduce cardiovascular and kidney disease risks in patients with type 2 diabetes-associated CKD, but not for HF.

Heart Failure 59

Heart Failure Blood Pressure Kidney Disease Diabetes 59

DAIC

JUNE 28, 2024

milla1cf Fri, 06/28/2024 - 19:07 June 28, 2024 — AstraZeneca has set out a new ambition for Healthy Heart Africa , its flagship health equity initiative, to target a broader range of non-communicable diseases (NCDs), including chronic kidney disease (CKD) as well as hypertension and cardiovascular disease.

Kidney Disease 111

Kidney Disease Blood Pressure Cardiovascular Disease Hypertension 111

Circulation

NOVEMBER 11, 2024

Background:The Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes (SUSTAIN-6) trial showed cardiovascular disease (CVD) benefits of semaglutide therapy in patients with type 2 diabetes mellitus (T2DM).Purpose:To year follow-up time).Results:Among Results:Among 5002 (projected to 34.0

Diabetes 40

Diabetes Blood Pressure Myocardial Infarction Kidney Disease 40

Hypertension Journal

NOVEMBER 13, 2023

BACKGROUND:Polycystic kidney disease is the most common hereditary kidney disorder with early and frequent hypertension symptoms. Molecular analysis was performed through transcriptomic profiling and biochemical approaches.RESULTS:Bsg-deficient mice exhibited significantly elevated arterial blood pressure.

Kidney Disease 40

Kidney Disease Blood Pressure Hypertension 40

Hypertension Journal

FEBRUARY 22, 2024

This article will review the origins of elevated blood pressure from when it was first appreciated in 2600 BC to its most recent emerging treatments. But really, it has only been since well after World War II that hypertension has finally been appreciated as the cause of so much heart, stroke, and kidney disease.

Hypertension 40

Hypertension Blood Pressure Kidney Disease Public Health 40

Open Heart

OCTOBER 31, 2024

Results Baseline characteristics revealed significant differences between NUA and HUA groups, with the latter exhibiting a higher prevalence of males, chronic kidney disease (CKD) and elevated levels of various biomarkers. in the NUA group. to 1.72, p=0.001).

Heart Failure 52

Heart Failure Kidney Disease Blood Pressure Biomarkers 52

Circulation

NOVEMBER 11, 2024

Background:Empagliflozin is a sodium glucose co-transporter 2 inhibitor that improves cardiovascular outcomes in patients with type 2 diabetes mellitus, chronic kidney disease and heart failure. Circulation, Volume 150, Issue Suppl_1 , Page A4121215-A4121215, November 12, 2024.

Myocardial Infarction 40

Myocardial Infarction Blood Pressure Heart Failure Kidney Disease 40

Stroke: Vascular and Interventional Neurology

MARCH 6, 2024

Susceptibility MMD genes, including ring finger protein 213/mysterin andGUCY1A3, have also been linked to extracranial vascular disease and increased systolic blood pressure. Blood pressure measurements and antihypertensive agent use were recorded pre‐ and postoperatively. After a mean follow‐up of 34.3±18.1

Hypertension 40

Hypertension Blood Pressure Pediatrics Kidney Disease 40

Heart BMJ

MAY 10, 2024

The associations of microvascular disease states (defined by the presence of retinopathy, peripheral neuropathy or chronic kidney disease), four modifiable arrhythmic risk factors (body mass index, smoking, systolic blood pressure and glycosylated haemoglobin) and their joint associations with incident arrhythmias were examined.

Risk Factors 52

Risk Factors Arrhythmia Diabetes Kidney Disease 52

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Additionally, 10% of the global population suffers from chronic kidney disease , with diabetes and hypertension as significant risk factors. Disparities in care are also concerning, with diagnosed cardiometabolic diseases varying up to twofold among different racial and ethnic groups. In the U.S.,

CME 96

CME Obesity Heart Failure Biomarkers 96

Hypertension Journal

JANUARY 29, 2024

Consistent recent data from randomized controlled trials show that potassium-enriched, sodium-reduced salt substitutes are an effective option for improving consumption levels and reducing blood pressure and the rates of cardiovascular events and deaths. Yet, salt substitutes are inconsistently recommended and rarely used.

Kidney Disease 40

Kidney Disease Hypertension Blood Pressure Risk Factors 40

Circulation

NOVEMBER 11, 2024

Introduction:High levels of blood pressure (BP) are responsible for 7.6 The diagnosis of hypertension is associated with a significant increase in the risk of kidney or cardiovascular events, with no prior history of these events. Circulation, Volume 150, Issue Suppl_1 , Page A4145840-A4145840, November 12, 2024.

Hypertension 40

Hypertension Heart Failure Certification Kidney Disease 40

Circulation

JANUARY 24, 2024

METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.

Heart Disease 81

Heart Disease Stroke Strokes Peripheral Arterial Disease 81

Journal of the American Heart Association

FEBRUARY 16, 2024

The developed model was validated internally and externally using an independent external cohort (n=138). Among 322 patients, 138 (42.9%) survived postdischarge.

Cardiogenic Shock 45

Cardiogenic Shock Hospital Myocardial Infarction Kidney Disease 45

Dr. Paddy Barrett

NOVEMBER 1, 2024

Death from heart disease: 51% reduction in risk. High Blood Pressure: 37% reduction in risk. Kidney Disease: 42% reduction in risk. Death from any cause: 53% reduction in risk. Cancer deaths: 43% reduction in risk. Heart Failure: 69% reduction in risk. Dementia: 64% reduction in risk. Let me be clear.

Exercise 118

Exercise Quality of Life Heart Disease Blood Pressure 118

Dr. Malcolm Kendrick

DECEMBER 8, 2023

Here, for example, plucked at random, is a reference to the latest NICE guidelines on the management of hypertension (high blood pressure) in adults. In addition, there are links to formal risk assessment in cardiovascular disease. No, we the mighty, have told you what constitutes perfect care for raised blood pressure.

Blood Pressure 126

Blood Pressure Blog Document Hypertension 126

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionAtherosclerosis, the hardening and narrowing of the arteries, occurs due to the buildup of plaque on the inner walls of the arteries which can result in reduced blood flow to the organs and tissues. Risk factors such as smoking, chronic kidney disease, and aging can contribute to plaque formation.

Risk Factors 40

Risk Factors Blood Pressure Chest Pain Plaque 40

Cardiometabolic Health Congress

JULY 17, 2024

Aprocitentan (Tryvio) Approved: March 20, 2024 Indication: Hypertension in adults Administration: Oral Mechanism: Endothelin A and B receptor antagonist Developer: Idorsia Pharmaceuticals Significance: First and only FDA-approved endothelin receptor antagonist for high blood pressure that remains uncontrolled with existing treatments.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59

Physiologically Speaking

DECEMBER 15, 2023

Effects of resistance training on traditional CVD risk factors Blood pressure Resistance exercise training has been shown to improve resting blood pressure in cohorts of healthy adults and adults with varying levels of high blood pressure.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Physiologically Speaking

DECEMBER 15, 2023

Effects of resistance training on traditional CVD risk factors Blood pressure Resistance exercise training has been shown to improve resting blood pressure in cohorts of healthy adults and adults with varying levels of high blood pressure.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Cardiometabolic Health Congress

JULY 10, 2024

Bakris’s distinguished career in medicine spanned over four decades, marked by significant contributions to the fields of diabetic kidney disease, hypertension, and nephropathy progression. His work was particularly influential in understanding racial disparities in disease progression and developing targeted interventions.

Hypertension 52

Hypertension Education Blood Pressure Kidney Disease 52

GEMMS

MAY 22, 2024

Traditional tools like stethoscopes, blood pressure gauges, and electrocardiograms (ECG) are fundamental for standard diagnostic practices. Gene-Based Analysis Predictive analytics is vital in reducing morbidity and mortality, with healthcare startups focusing on early risk prediction and disease detection.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

Cardiometabolic Health Congress

AUGUST 14, 2024

The focus will be on the intricate interplay between cardiorenal and metabolic conditions, such as type 2 diabetes, cardiovascular disease, and chronic kidney disease, driven by lifestyle and health factors.

CME 72

CME Education Diabetes Innovation 72

DAIC

MAY 16, 2024

Among those ages 65 and older, nearly 50% who underwent limb amputation died within one year after surgery, according to the 2024 Heart Disease and Stroke Statistics: A Report of U.S. and Global Data From the American Heart Association. All patients with PAD should be treated with high-intensity statin therapy.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Quality of Life Ischemia 105